Demant A/S
Research Demant A/S (DEMANT) on Bullrun: market cap DKK 66.22B, P/E 27.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDEMANT
- ExchangeCO
- CountryDenmark
- SectorHealthcare
- IndustryMedical Devices
- CurrencyDKK
- Market capDKK 66.22B
- P/E27.4
- Financial periodFY2025
- RevenueDKK 22.97B
- Revenue growth2.5%
- Net incomeDKK 1.55B
- Free cash flowDKK 3.00B
- Gross margin75.6%
Valuation Snapshot
latest market cap is DKK 66.22B; P/E is 27.4.
Peer valuation comparison
Latest P/E is 27.38x versus a Healthcare sector median of 24.61x (11.2% above).
Latest P/E is 27.38x versus a Denmark median of 17.65x (55.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | DKK 22.97B | DKK 1.55B | DKK 3.00B | 75.6% | 7.31 | DKK 1.33B | DKK 20.99B | DKK 9.84B |
| FY2024 | DKK 22.42B | DKK 2.39B | DKK 3.30B | 76.2% | 10.99 | DKK 1.11B | DKK 15.68B | DKK 9.56B |
| FY2023 | DKK 21.60B | DKK 1.80B | DKK 3.62B | 75.6% | 8.04 | DKK 1.14B | DKK 14.45B | DKK 9.26B |
| FY2022 | DKK 19.71B | DKK 2.08B | DKK 1.70B | 74.4% | 9.21 | DKK 1.13B | DKK 15.08B | DKK 8.56B |
| FY2021 | DKK 17.91B | DKK 2.53B | DKK 3.03B | 75.2% | 10.7 | DKK 1.17B | DKK 9.22B | DKK 7.98B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-02 | DKK 66.22B | 27.4 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 DKK.
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019.
ETFs that hold Demant A/S
Demant A/S is one of the ten largest holdings of one ETF that investors in Europe can buy:
| ETF | Weight | TER |
|---|---|---|
| iShares MSCI Europe Mid-Cap Equal Weight UCITS ETF | 0.62% | 0.25% |
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Demant A/S's market cap?
Demant A/S's market capitalization is DKK 66.22B.
What is Demant A/S's P/E ratio?
Demant A/S's price-to-earnings (P/E) ratio is 27.4.
What does Demant A/S do?
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.